Prediction of Clinical Transporter‐Mediated Drug–Drug Interactions via Comeasurement of Pitavastatin and Eltrombopag in Human Hepatocyte Models-Reference-Cited by-同舟云学术

Prediction of Clinical Transporter‐Mediated Drug–Drug Interactions via Comeasurement of Pitavastatin and Eltrombopag in Human Hepatocyte Models

Author:

Carter Simon J.¹,Chouhan Bhavik²,Sharma Pradeep³,Chappell Michael J.¹

Affiliation:

1. Biomedical and Biological Systems Laboratory School of Engineering University of Warwick Coventry UK

2. Functional & Mechanistic Safety Clinical Pharmacology & Safety SciencesR&DAstraZeneca R&D Gothenburg Sweden

3. Clinical Pharmacology & Quantitative Pharmacology Clinical Pharmacology & Safety Sciences R&D, AstraZeneca R&D Cambridge UK

Funder

Biotechnology and Biological Sciences Research Council

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

Reference43 articles.

3. Australian Government Therapeutic Goods Administration.Australian public assessment report for pitavastatin (2013).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献